ask="2.49"
ask_size="100"
average_daily_volume="548892"
bid="2.26"
bid_size="5000"
book_value="4.01"
change="-0.10"
change_from_200_day_moving_average="-2.74"
change_from_50_day_moving_average="0.13"
change_from_52_week_high="-7.01"
change_From_52_week_low="0.34"
change_in_percent="-4.10%"
close="2.34"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.96"
ebitda="-30.59M"
eps_estimate_current_year="-2.09"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.88"
ex_dividend_date="N/A"
float_shares="8428000"
high="2.46"
high_52_weeks="9.35"
last_trade_date="2/6/2017"
last_trade_price="2.34"
last_trade_size="5500"
last_trade_time="4:00pm"
low="2.32"
low_52_weeks="2.00"
market_capitalization="36.37M"
moving_average_200_day="5.08"
moving_average_50_day="2.21"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.63"
open="2.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-53.94%"
percent_change_from_50_day_moving_average="+5.79%"
percent_change_from_52_week_high="-74.97%"
percent_change_from_52_week_low="+17.00%"
previous_close="2.44"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.61"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15543000"
short_ratio="0.44"
stock_exchange="NGM"
symbol="NVLS"
volume="405403"
weeks_range_52="2.00 - 9.35"
